Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP – Glanil M1 Tablets

Glanil M1 Tablets – Two Powerful Forces with Effective Solution for Diabetes.

Glanil M1 Tablets – The combination of metformin hydrochloride prolonged release and glimepiride tablets ip is used to treat diabetes and treat high sugar levels and which Glimepiride works by stimulating beta cells in the pancreas that produce insulin. Thus, insulin helps to remove sugar from the blood. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin, which enables these cells to remove sugar more effectively from the blood.

KEY BENEFITS of Metformin Hydrochloride Prolonged Release & Glimepiride Tablets IP – Glanil M1 Tablets
✅Dual Mechanism of Action: To stimulate insulin release from the pancreas, while Metformin improves insulin sensitivity and reduces glucose production in the liver, providing comprehensive blood sugar control.
✅Effective for Both and Advanced Type 2 Diabetes: The combination is effective in managing Type 2 Diabetes at various stages of the condition, from initial insulin resistance to later stages when insulin secretion also declines.
✅Improved Patient Compliance: To simplify the treatment regimen, improving patient adherence by reducing the number of tablets and doses needed daily.

Recommended By Specialists:
👨‍⚕️Endocrinologists: To manage diabetes and metabolic disorders, endocrinologists often prescribe this combination therapy for patients with Type 2 Diabetes, especially when blood sugar control with diet and exercise alone is insufficient.
👨‍⚕️General Physicians: Basically it is used to treat to prescribe this combination for Type 2 Diabetes management, especially for patients who require both insulin release stimulation and improved insulin sensitivity.
👨‍⚕️Internal Medicine Specialists: As it often prefers combination therapy for diabetes management in patients with Type 2 Diabetes and additional health complications.

INDICATIONS:
✅Type 2 Diabetes Mellitus
✅Improved Glycemic Control
✅For Patients with Insulin Resistance and Insulin Deficiency